| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/25/1996 | EP0733057A1 Origin of replication complex genes, proteins and methods |
| 09/25/1996 | EP0733046A1 Novel benzoyl guanidines, their production and their use in medicaments |
| 09/25/1996 | EP0733045A1 4,6-dianilino-pyrimidine derivatives, their preparation and their use as tyrosine kinase inhibitors |
| 09/25/1996 | EP0733035A1 Tricyclic derivatives, pharmaceutical compositions containing them |
| 09/25/1996 | EP0732943A1 Three-step pretargeting methods and compounds |
| 09/25/1996 | EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 09/25/1996 | EP0732938A1 Method of treating intestinal disorders |
| 09/25/1996 | EP0732934A1 Long-acting injection suspensions and a process for their preparation |
| 09/25/1996 | EP0732929A1 Therapeutic use of cis-element decoys in vivo |
| 09/25/1996 | EP0732921A1 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide |
| 09/25/1996 | EP0674513B1 Retroviral protease inhibiting compounds |
| 09/25/1996 | EP0458829B1 Methods and compositions for treatment of cancer using oligonucleotides |
| 09/25/1996 | CN1131946A Distamycin A analogues as antitumour or antiviral agents |
| 09/25/1996 | CN1131939A Oxidizer carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and antitumor agents |
| 09/25/1996 | CN1131665A Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
| 09/25/1996 | CA2171518A1 Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides |
| 09/24/1996 | US5559248 For prevention and treatment of skin disorders |
| 09/24/1996 | US5559232 Anticoagulants |
| 09/24/1996 | US5559222 Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose |
| 09/24/1996 | US5559211 Biologically active product produced by streptococcus pyogenes and method of purification |
| 09/24/1996 | US5559153 Antiarrhythmia agents; cardiovascular disorders |
| 09/24/1996 | US5559148 Parenteral busulfan for treatment of malignant disease |
| 09/24/1996 | US5559141 Selective aromatase inhibiting 4(5)-imidazoles |
| 09/24/1996 | US5559122 Hindered N-oxide esters of rapamycin |
| 09/24/1996 | US5559121 Rapamycin formulations for oral administration |
| 09/24/1996 | US5559113 Imidazole compounds and their therapeutic applications |
| 09/24/1996 | US5559101 Antitumor, anticarcinogenic, hiv |
| 09/24/1996 | US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof |
| 09/24/1996 | US5558877 For vaginal insertion, silicone elastomer ring, tamoxifen |
| 09/24/1996 | US5558866 Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof |
| 09/24/1996 | US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies |
| 09/24/1996 | US5558085 Intrapulmonary delivery of peptide drugs |
| 09/24/1996 | CA2172436A1 Compositions and methods for increasing the immunogenicity of tumor cells |
| 09/24/1996 | CA2022538C N-(vincristinoyl-23) and n-(noranhydro-5'vinblastinoyl-23) derivatives of amino-1 methylphosphonic acid, process for their preparation and pharmaceutical compositions containing the same |
| 09/22/1996 | CA2172211A1 Treatment and prevention of prostatic cancer |
| 09/22/1996 | CA2172111A1 Nanosuspensions for intravenous administration |
| 09/22/1996 | CA2172110A1 Pharmaceutical carriers for nanosuspensions |
| 09/19/1996 | WO1996028730A1 Method of identifying molecules that regulate fgf activity |
| 09/19/1996 | WO1996028569A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same |
| 09/19/1996 | WO1996028564A1 Novel recombinant dna vectors for gene therapy |
| 09/19/1996 | WO1996028555A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 09/19/1996 | WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 09/19/1996 | WO1996028462A1 17-difluoromethylene-oestratrienes |
| 09/19/1996 | WO1996028461A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF |
| 09/19/1996 | WO1996028435A1 Cephalomannine epoxide, its analogues and a method for preparing the same |
| 09/19/1996 | WO1996028430A1 Trisubstituted phenyl derivatives |
| 09/19/1996 | WO1996028425A1 Piperidinyl-2-alkyl subst. linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| 09/19/1996 | WO1996028412A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 09/19/1996 | WO1996028178A1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 09/19/1996 | WO1996028175A1 Immunomodulating compositions from bile for the treatment of immune system disorders |
| 09/19/1996 | WO1996028160A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
| 09/19/1996 | WO1996028152A1 Novel benzofuran pharmaceutical compounds |
| 09/19/1996 | WO1996028146A1 Novel naphthyl pharmaceutical compounds |
| 09/19/1996 | WO1996028144A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 09/19/1996 | WO1996021463A3 New applications of lysozyme dimer |
| 09/19/1996 | WO1996019499A3 Improved cyclic crf antagonists |
| 09/19/1996 | DE19509729A1 17-Difluormethylen-Estratriene 17-difluoromethylene estratrienes |
| 09/19/1996 | CA2215391A1 Method of identifying molecules that regulate fgf activity |
| 09/19/1996 | CA2215201A1 17-difluoromethylene-estratrienes |
| 09/19/1996 | CA2215046A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
| 09/19/1996 | CA2215016A1 Isolated nucleic acid molecules which are members of the mage-xp family and uses thereof |
| 09/19/1996 | CA2214993A1 Cephalomannine epoxide, its analogues and a method for preparing the same |
| 09/19/1996 | CA2214450A1 Novel benzofuran pharmaceutical compounds |
| 09/19/1996 | CA2214416A1 Novel naphthyl pharmaceutical compounds |
| 09/18/1996 | EP0731838A1 Binding structures directed against the ca55.1 antigen |
| 09/18/1996 | EP0731835A1 Antisense oligonucleotides having tumorigenicity-inhibiting activity |
| 09/18/1996 | EP0731811A1 Chaperonin 10 |
| 09/18/1996 | EP0731810A1 Double-chain hemoregulatory peptides |
| 09/18/1996 | EP0731808A1 Nucleosides and oligonucleotides containing boron clusters |
| 09/18/1996 | EP0731790A1 Tachykinin antagonists |
| 09/18/1996 | EP0731789A1 Dp-iv-serine protease inhibitors |
| 09/18/1996 | EP0731712A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 09/18/1996 | EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/18/1996 | EP0637964B1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy |
| 09/18/1996 | EP0624090B1 Reversal of multi-drug resistance by tetraarylethylenes |
| 09/18/1996 | EP0593625B1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 09/18/1996 | EP0553248B1 Novel 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents |
| 09/18/1996 | EP0541780B1 Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof |
| 09/18/1996 | CN1131437A Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 09/18/1996 | CN1131420A Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 09/18/1996 | CN1131415A Triaryl-ethylene derivatives for use in therapy |
| 09/18/1996 | CN1131037A Yingfengaidi medicine and its production process |
| 09/17/1996 | US5556983 Phenylimidazolidines |
| 09/17/1996 | US5556942 Glutathione S-transferase-activated compounds |
| 09/17/1996 | US5556939 TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
| 09/17/1996 | US5556877 Antitumor agents |
| 09/17/1996 | US5556870 Use of leflunomide for inhibiting interleukin 1 beta |
| 09/17/1996 | US5556856 Anitarrhythmia, analgesics |
| 09/17/1996 | US5556849 Ruthenium containing phthalocyanin photosensitizers |
| 09/17/1996 | US5556845 11-β substituted-19-nor steroids |
| 09/17/1996 | US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c |
| 09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
| 09/17/1996 | US5556626 Antineoplastic drug of plant origin and process for the preparation thereof |
| 09/17/1996 | US5556611 Preventing and treating mucosal diseases of epithelia of tracheobronchial tract by topically applying aerosol inhalate comprising ester of retinoic acid or ester of retinol; particles of specified size |
| 09/12/1996 | WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 09/12/1996 | WO1996027663A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells |
| 09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/12/1996 | WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 09/12/1996 | WO1996027594A1 Antitumour isocoumarins |
| 09/12/1996 | WO1996027583A1 Arylsulfonylamino hydroxamic acid derivatives |